Having trouble accessing articles? Reset your cache.

Elan buys back $1B in stock, Royalty Pharma ups bid

Elan Corp. plc (NYSE:ELN) used $1 billion to repurchase 88.9 million shares, or about 14.8%, at

Read the full 168 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE